Overview and Scope
Blood culture tests refer to blood tests used to detect and identify disease-causing microorganisms in the bloodstream. A blood culture test checks for infections caused by microorganisms like bacteria, yeast, and other foreign invaders in a blood sample.
Sizing and Forecast
The blood culture tests market size has grown rapidly in recent years. It will grow from <b>$6.22 billion in 2023 to $6.97 billion in 2024 at a compound annual growth rate (CAGR) of 12.1%. </b> The growth in the historic period can be attributed to increase in prevalence of infectious diseases, aging population, advances in healthcare infrastructure, rise in research and development.
The blood culture tests market size is expected to see rapid growth in the next few years. It will grow to <b>$11.46 billion in 2028 at a compound annual growth rate (CAGR) of 13.2%. </b> The growth in the forecast period can be attributed to rising hospital-acquired infections, growing demand for point-of-care (poc) testing, increased healthcare spending, regulatory approvals. Major trends in the forecast period include telemedicine and remote testing, automation and ai, multiplex testing, sepsis management, infectious disease surveillance.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/blood-culture-tests-global-market-report
Segmentation & Regional Insights
The blood culture tests market covered in this report is segmented –
1) By Method: Conventional/Manual Methods, Automated Methods
2) By Product: Consumables, Instruments, Software and Services
3) By Technology: Culture-Based Technology, Molecular Technologies, Microarrays, PCR (Polymerase Chain Reaction), PNA-FiSH (Peptide Nucleic Acid – Fluroscent in Situ Hybridization), Proteomics Technology
4) By Application: Bacteremia, Fungemia, Mycobacterial Detection
5) By End User: Hospital Laboratories, Reference Laboratories, Academic Research Laboratories, Other Laboratories
<b>North America</b> was the largest region in the blood culture tests market in 2023. The regions covered in the blood culture tests market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7763&type=smp
Major Driver Impacting Market Growth
The increase in incidence of infectious diseases is expected to propel the growth of the blood culture test market. Infectious diseases are illnesses caused by pathogens, including viruses, bacteria, fungi, and parasites. These diseases have dangerous microorganisms or pathogens that enter an individual’s body from the outside or from an infected person. These infectious diseases, such as COVID-19, tuberculosis, flu, measles, HIV, strep throat, and so on, have the potential to cause momentary pain, significant tissue damage, or even death. The World Health Organization ranks infectious diseases as the second biggest cause of death globally. These increases in the incidence of infectious diseases have led to an increase in the demand for blood culture tests to assist in determining whether a patient has bacteremia/septicemia, a potentially fatal condition, or not. For instance, in 2022, the World Health Organization, stated that approximately 6.4 million people died from COVID-19. Furthermore, due to tuberculosis (TB), a total of 1.5 million people died in 2020 worldwide. Therefore, the increasing incidence of infectious diseases is driving the growth of the blood culture test market.
Key Industry Players
Major companies operating in the blood culture tests market include <b> Becton, Dickinson and Company, BioMerieux SA, Thermo Fisher Scientific Inc., Luminex Corporation, Danaher Corporation, Terumo Corporation, Bruker Corporation, F. Hoffmann-La Roche AG, Biobase Biotech Co. Ltd., Scenker Biological Technology Co. Ltd., Bulldog Bio, Anaerobe Systems Inc., Himedia Laboratories Pvt. Ltd., Autobio Diagnostics Co. Ltd., Axiom Laboratories, Biosystems Inc., BINDER GmBH, Roche Diagnostics, Mikroscan Technologies Inc., Labotronics Ltd., Hardy Diagnostics, OpGen Inc., Meditech Technologies India Private Limited, Siemens Healthineers, Abbott Laboratories, Cepheid, T2 Biosystems Inc., Beckman Coulter Inc., Accelerate Diagnostics, Bio-Rad Laboratories Inc., Hologic Inc., Quidel Corporation, Copan Diagnostics Inc., Greiner Bio-One International GmbH, Carl Zeiss AG, Nanosphere Health Sciences, GenMark Diagnostics, Meridian Bioscience Inc., Nikon Corporation </b>
The blood culture tests market report table of contents includes:
1. Executive Summary
2. Blood Culture Tests Market Characteristics
3. Blood Culture Tests Market Trends And Strategies
4. Blood Culture Tests Market – Macro Economic Scenario
5. Global Blood Culture Tests Market Size and Growth
.
.
.
26. South America Blood Culture Tests Market
27. Brazil Blood Culture Tests Market
28. Middle East Blood Culture Tests Market
29. Africa Blood Culture Tests Market
30. Blood Culture Tests Market Competitive Landscape And Company Profiles
Top Major Players:
- Becton
- Dickinson and Company
- BioMerieux SA
- Thermo Fisher Scientific Inc
- Luminex Corporation
Explore the trending research reports from TBRC:
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
